Alcon bought Aerie Pharmaceuticals Aerie Pharmaceuticals from 11/22/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Alcon completed its acquisition of Aerie Pharmaceuticals for $770 million, or 15.25 per share.

Aerie Pharmaceuticals

Review

Source:

{source} pictogram

investor.alcon.com

Vladimir Petenev

News editor

Write your comment first

News feed

Perm suspended the operation of kickshare services

4/15/24 WUSH

Ural Forge reported for 2023 by IFRS

4/15/24 URKZ

Board of Directors of Acron recommended dividends

4/15/24 AKRN

Lukoil opened the first gas station in Kazakhstan

4/15/24 LKOH

Chelyabinsk Metallurgical Plant reported for 2023 by IFRS

4/15/24 CHMK

Magnit started rebranding of KazanExpress marketplace

4/15/24 MGNT

Board of Directors of RPA Nauka recommended dividends

4/15/24 NAUK

Bank of Russia may restrict access to shares of non-transparent companies

4/15/24 MOEX

Astra conducts SPO to increase free-float

4/15/24 ASTR

Element Group selected SPB Exchange for IPO

4/15/24 SPBE